(Q37215983)

19 August 2017

Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome (English)

1 reference

19 August 2017

1 reference

endometrial carcinoma

1 reference

Gassel AM

1

1 reference

19 August 2017

Backe J

2

1 reference

19 August 2017

Krebs S

3

1 reference

19 August 2017

Schön S

4

1 reference

19 August 2017

Caffier H

5

1 reference

19 August 2017

Müller-Hermelink HK

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Journal of Clinical Pathology

19 August 2017

1 reference

19 August 2017

51

1 reference

19 August 2017

1

1 reference

19 August 2017

25-29

1 reference

Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Antibody for detecting p53 protein by immunohistochemistry in normal tissues

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

The prognostic significance of surgical staging for carcinoma of the endometrium

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Adenocarcinoma of the uterine corpus.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Tumor size in endometrial cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

The value of immunohistochemistry in the differential diagnosis of endometrial carcinomas

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Growth potential of endometrial cancers assessed by a Ki-67 Ag/DNA dual-color flow-cytometric assay

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Overexpression and mutation of p53 in endometrial carcinoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Immunohistochemical study of the human 17 beta-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500426

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]

3 September 2018

1 reference

12 December 2020

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium

1 reference

12 December 2020

Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma

1 reference

12 December 2020

Deletions of 17p and p53 mutations in preneoplastic lesions of the lung

1 reference

12 December 2020

Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy

1 reference

12 December 2020

Prognostic significance of hormone receptors in endometrial cancer

1 reference

12 December 2020

Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status

1 reference

12 December 2020

Proliferative activity as revealed by Ki-67 in uterine adenocarcinoma of endometrioid type: comparison of tumours from patients with and without previous oestrogen therapy

1 reference

12 December 2020

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53

1 reference

12 December 2020

Clinicopathological characteristics of p53 overexpression in endometrial cancers

1 reference

12 December 2020

Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness

1 reference

12 December 2020

Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer

1 reference

12 December 2020

Proliferation index determined by MIB-1 and recurrence in endometrial cancer

1 reference

12 December 2020

[Tumor suppressor gene p53. Theoretical principles and their significance for pathology]

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.51.1.25

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

9577367

1 reference